Personalized medicine in biomarker identification at their optimal cut-off selection

Personalized medicine in biomarker identification at their optimal cut-off selection

Bibliographic Details
Main Author:	Tadeusz Lewandowski
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-10-01
Series:	Gastroenterology Review
Subjects:	personalised medicine cross validation oncology
Online Access:	https://www.termedia.pl/Personalized-medicine-in-biomarker-identification-at-their-optimal-cut-off-selection,41,48025,1,1.html

Similar Items

From Personalized Medicine to Precision Psychiatry?
by: Češková E, et al.
Published: (2021-12-01)

A survey of experts on personalized medicine landscape in European Union and China
by: Ilda Hoxhaj, et al.
Published: (2023-05-01)

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
by: Matthew G. Davey, et al.
Published: (2021-08-01)

Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases
by: Steven L. Wood, et al.
Published: (2020-07-01)

What Personalized Medicine Humans Need and Way to It ——also on the Practical Significance and Scientific Limitations of Precision Medicine
by: Yuan B
Published: (2022-11-01)

Insights into Personalised Medicine in Bronchiectasis
by: Clementine S. Fraser, et al.
Published: (2023-01-01)

The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate
by: Hector Guadalajara, et al.
Published: (2022-02-01)

A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine
by: Anne T. Collins, et al.
Published: (2018-11-01)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
by: Matthew G. Davey, et al.
Published: (2021-10-01)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
by: Matthew G. Davey, et al.
Published: (2022-08-01)

Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine
by: Bozhidar-Adrian Stefanov, et al.
Published: (2022-09-01)

Prospects for the Management of Sepsis in an Era of Personalised Medicine
by: Jonathan Cohen
Published: (2019-03-01)

Precision Medicine in Lung Cancer
by: Esha Joshi
Published: (2020-01-01)

The impact of personalised therapies on respiratory medicine
by: J. Stuart Elborn
Published: (2013-03-01)

Personalised Medicine: The Odyssey from Hope to Practice
by: Sophie Visvikis-Siest, et al.
Published: (2018-09-01)

How personalised medicine will transform healthcare by 2030: the ICPerMed vision
by: Astrid M. Vicente, et al.
Published: (2020-04-01)

“Medicine 4.0”
by: Wolf Bernhard, et al.
Published: (2017-09-01)

ODMedit: uniform semantic annotation for data integration in medicine based on a public metadata repository
by: Martin Dugas, et al.
Published: (2016-06-01)

Multiple Myeloma: Personalised Medicine Based on Pathogenesis
by: Wen-Chi Yang, et al.
Published: (2018-03-01)

Barriers and Facilitators to the Implementation of Personalised Medicine across Europe
by: Dorota Stefanicka-Wojtas, et al.
Published: (2023-01-01)

Recommendations for robust and reproducible preclinical research in personalised medicine
by: Vibeke Fosse, et al.
Published: (2023-01-01)

Polypharmacy and precision medicine
by: Kenji Fujita, et al.
Published: (2023-01-01)

PERSONALISED MEDICINE IN BRONCHIAL ASTHMA: CURRENT CONCEPTS AND PROSPECTS
by: R.M. FAYZULLINA, et al.
Published: (2021-09-01)

From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalised Medicine
by: Jeremy Everett
Published: (2016-09-01)

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial
by: Benjamin Kye Jyn Tan, et al.
Published: (2021-04-01)

Editorial: Implementation of genomic medicine in Africa: One continent, one vision
by: Maritha J. Kotze, et al.
Published: (2023-01-01)

The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
by: Chang Su, et al.
Published: (2023-01-01)

Successful long‐term treatment of pyoderma gangrenosum with secukinumab
by: Fabienne Froehlich, et al.
Published: (2023-06-01)

The genetics of gout: towards personalised medicine?
by: Nicola Dalbeth, et al.
Published: (2017-05-01)

Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals’ education and citizens’ empowerment in personalised medicine
by: Flavia Beccia, et al.
Published: (2023-06-01)

Editorial: Insights in respiratory pharmacology: 2021
by: Paolo Montuschi, et al.
Published: (2022-11-01)

Patient-specific Boolean models of signalling networks guide personalised treatments
by: Arnau Montagud, et al.
Published: (2022-02-01)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
by: Matthew G. Davey, et al.
Published: (2021-09-01)

Application of personalised medicine to solid tumours: opportunities and challenges
by: Christian Ruiz, et al.
Published: (2012-06-01)

Personalized e-learning in Moodle: the Moodle_LS System
by: Carla Limongelli, et al.
Published: (2011-01-01)

When should we order a next generation sequencing test in a patient with cancer?
by: Ramon Colomer, et al.
Published: (2020-08-01)

A Pathway to Precision Medicine for Aboriginal Australians: A Study Protocol
by: Yeu-Yao Cheng, et al.
Published: (2021-06-01)

Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine
by: Anaïs Chauvin, et al.
Published: (2018-12-01)

Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine
by: Henry J. Martell, et al.
Published: (2017-08-01)

Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion
by: Denis Horgan, et al.
Published: (2020-12-01)